Dan Turner - Profile and Investment Details

Investor Profile

Dan Turner is a Venture Capital, Private Equity Firm, Micro VC based in Menlo Park, California, United States with a diverse investment portfolio that includes companies such as Novalar Pharmaceuticals, StorageWay, Colorescience, Transcept Pharmaceuticals, Internet Generation Storage, NovoStent Corporation, NovaCardia, Avera Pharmaceutical, PartnerGate, Avantis Medical Systems, Verus Pharmaceuticals, SI-BONE, Pulmonx, Peninsula Pharmaceuticals, Pivot Medical, Somaxon Pharmaceuticals, Epirus BiopharmaceuticalsCephren, Marketwired, GC Aesthetics, Cerexa Inc., Sequel Pharmaceuticals, Pure Life Renal, MAKO Surgical, moksha8 Pharmaceuticals, SkinMedica, Crown Laboratories, Kareo, Orexigen Therapeutics, Tobira Therapeutics, MINDBODY, KFx Medical, TigerConnect, ARYx Therapeutics, Bayhill Therapeutics, Glaukos, FinPay, Asthmatx, NeurogesX, . Over time, Dan Turner has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Dan Turner is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, E-commerce, Cybersecurity, Messaging, Women Founded, Enterprise Software, Lifestyle Products, Banking, Cloud Computing, Finance, Software, Manufacturing, Fashion, Cosmetics, Electronic Health Records (EHR), Legal Tech, FinTech, Natural Language Processing, B2C, Health Diagnostics, Digital Health, Medical, Big Data, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Dan Turner, as their portfolio suggests a familiarity and interest in this area.

Understanding Dan Turner’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.